Literature DB >> 21622562

Silencing suppressor of cytokine signaling-1 (SOCS1) in macrophages improves Mycobacterium tuberculosis control in an interferon-gamma (IFN-gamma)-dependent manner.

Berit Carow1, Xiang qun Ye, Dolores Gavier-Widén, Sabin Bhuju, Wulf Oehlmann, Mahavir Singh, Markus Sköld, Lech Ignatowicz, Akihiko Yoshimura, Hans Wigzell, Martin E Rottenberg.   

Abstract

Protection against infection with Mycobacterium tuberculosis demands IFN-γ. SOCS1 has been shown to inhibit responses to IFN-γ and might thereby play a central role in the outcome of infection. We found that M. tuberculosis is a highly efficient stimulator of SOCS1 expression in murine and human macrophages and in tissues from infected mice. Surprisingly, SOCS1 reduced responses to IL-12, resulting in an impaired IFN-γ secretion by macrophages that in turn accounted for a deteriorated intracellular mycobacterial control. Despite SOCS1 expression, mycobacteria-infected macrophages responded to exogenously added IFN-γ. SOCS1 attenuated the expression of the majority of genes modulated by M. tuberculosis infection of macrophages. Using a conditional knockdown strategy in mice, we found that SOCS1 expression by macrophages hampered M. tuberculosis clearance early after infection in vivo in an IFN-γ-dependent manner. On the other hand, at later time points, SOCS1 expression by non-macrophage cells protected the host from infection-induced detrimental inflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21622562      PMCID: PMC3143647          DOI: 10.1074/jbc.M111.238287

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

Authors:  O Takeuchi; K Hoshino; T Kawai; H Sanjo; H Takada; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

2.  Isolation and culture of human macrophages.

Authors:  John Q Davies; Siamon Gordon
Journal:  Methods Mol Biol       Date:  2005

3.  Conditional gene targeting in macrophages and granulocytes using LysMcre mice.

Authors:  B E Clausen; C Burkhardt; W Reith; R Renkawitz; I Förster
Journal:  Transgenic Res       Date:  1999-08       Impact factor: 2.788

4.  RAG-1-deficient mice have no mature B and T lymphocytes.

Authors:  P Mombaerts; J Iacomini; R S Johnson; K Herrup; S Tonegawa; V E Papaioannou
Journal:  Cell       Date:  1992-03-06       Impact factor: 41.582

5.  Immune response in mice that lack the interferon-gamma receptor.

Authors:  S Huang; W Hendriks; A Althage; S Hemmi; H Bluethmann; R Kamijo; J Vilcek; R M Zinkernagel; M Aguet
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

6.  Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function.

Authors:  Lawrence O Flowers; Howard M Johnson; Mustafa G Mujtaba; Morgan R Ellis; S Mohammed I Haider; Prem S Subramaniam
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

7.  Mycobacterium bovis bacillus Calmette-Guérin infection promotes SOCS induction and inhibits IFN-gamma-stimulated JAK/STAT signaling in J774 macrophages.

Authors:  Kenichi Imai; Tomoko Kurita-Ochiai; Kuniyasu Ochiai
Journal:  FEMS Immunol Med Microbiol       Date:  2003-11-28

8.  MyD88 primes macrophages for full-scale activation by interferon-gamma yet mediates few responses to Mycobacterium tuberculosis.

Authors:  Shuangping Shi; Carl Nathan; Dirk Schnappinger; Jörg Drenkow; Michele Fuortes; Ellen Block; Aihao Ding; Thomas R Gingeras; Gary Schoolnik; Shizuo Akira; Kiyoshi Takeda; Sabine Ehrt
Journal:  J Exp Med       Date:  2003-09-29       Impact factor: 14.307

9.  Disseminated tuberculosis in interferon gamma gene-disrupted mice.

Authors:  A M Cooper; D K Dalton; T A Stewart; J P Griffin; D G Russell; I M Orme
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

10.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  24 in total

Review 1.  Tuberculosis and HIV Coinfection.

Authors:  Judith Bruchfeld; Margarida Correia-Neves; Gunilla Källenius
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-26       Impact factor: 6.915

2.  Failure to recruit anti-inflammatory CD103+ dendritic cells and a diminished CD4+ Foxp3+ regulatory T cell pool in mice that display excessive lung inflammation and increased susceptibility to Mycobacterium tuberculosis.

Authors:  Chaniya Leepiyasakulchai; Lech Ignatowicz; Andrzej Pawlowski; Gunilla Källenius; Markus Sköld
Journal:  Infect Immun       Date:  2012-01-03       Impact factor: 3.441

Review 3.  Macrophage immunoregulatory pathways in tuberculosis.

Authors:  Murugesan V S Rajaram; Bin Ni; Claire E Dodd; Larry S Schlesinger
Journal:  Semin Immunol       Date:  2014-10-30       Impact factor: 11.130

4.  SOCS1 is a negative regulator of metabolic reprogramming during sepsis.

Authors:  Annie Rocio Piñeros Alvarez; Nicole Glosson-Byers; Stephanie Brandt; Soujuan Wang; Hector Wong; Sarah Sturgeon; Brian Paul McCarthy; Paul R Territo; Jose Carlos Alves-Filho; C Henrique Serezani
Journal:  JCI Insight       Date:  2017-07-06

5.  Primary Role of Suppressor of Cytokine Signaling 1 in Mycobacterium bovis BCG Infection.

Authors:  Shogo Soma; Satoru Kawai; Hiroyasu Inada; Kenta Watanabe; Satoru Mizuno; Seiichi Kato; Kazuhiro Matsuo; Yasuhiro Yasutomi
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

Review 6.  Tuberculosis and HIV co-infection.

Authors:  Andrzej Pawlowski; Marianne Jansson; Markus Sköld; Martin E Rottenberg; Gunilla Källenius
Journal:  PLoS Pathog       Date:  2012-02-16       Impact factor: 6.823

7.  Critical and independent role for SOCS3 in either myeloid or T cells in resistance to Mycobacterium tuberculosis.

Authors:  Berit Carow; Ann-Kathrin Reuschl; Dolores Gavier-Widén; Brendan J Jenkins; Matthias Ernst; Akihiko Yoshimura; Benedict J Chambers; Martin E Rottenberg
Journal:  PLoS Pathog       Date:  2013-07-04       Impact factor: 6.823

Review 8.  SOCS3, a Major Regulator of Infection and Inflammation.

Authors:  Berit Carow; Martin E Rottenberg
Journal:  Front Immunol       Date:  2014-02-19       Impact factor: 7.561

9.  SOCS, Inflammation, and Autoimmunity.

Authors:  Akihiko Yoshimura; Mayu Suzuki; Ryota Sakaguchi; Toshikatsu Hanada; Hideo Yasukawa
Journal:  Front Immunol       Date:  2012-03-12       Impact factor: 7.561

10.  Macrophage control of phagocytosed mycobacteria is increased by factors secreted by alveolar epithelial cells through nitric oxide independent mechanisms.

Authors:  Dagbjort H Petursdottir; Olga D Chuquimia; Raphaela Freidl; Carmen Fernández
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.